GIRK2 deficient mice: Evidence for hyperactivity and reduced anxiety

Physiology and Behavior

Volumn 74, Issue 1-2, 2001, Pages 109-117

  Blednov, Yuri A ^a   Stoffel, M ^b   Chang, S R ^a   Harris, R Adron ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Anxiety; Canopy; Elevated plus maze; Isolation; Knockout mice; Light dark box; Locomotor activity

Indexed keywords

DOPAMINE 3 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; CONFERENCE PAPER; CONTROLLED STUDY; HYPERACTIVITY; LIGHT DARK CYCLE; LOCOMOTION; MAZE TEST; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SOCIAL ISOLATION;

EID: 0034823045     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(01)00555-8     Document Type: Conference Paper

References (72)

1. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
2. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
3. The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze
4. An ethoexperimental approach to the study of defense
5. Risk assessment and animal models of anxiety
6. GIRK2 null mutant mice are hyperactive and supersensitive to locomotor stimulatory effects of ethanol and dopamine D1 agonists
7. Further characterization of a simple automated exploratory model for the anxiolytic effects of benzodiazepines
8. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA
9. Mice lacking PKC gamma exhibit decreased anxiety
10. Anxiety-and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests
11. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6208) in the murine elevated plus-maze
12. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor
13. Exploration of mice in a black and white test box: Validation as a model of anxiety
14. Animal models of anxiety
15. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
16. Neuropharmacological specificity of a simple animal model for the behavioral actions of benzodiazepines
17. Unusual behavioral phenotypes of inbred mouse strains
18. Neuropharmacological specificity of simple, animal model for the behavioural actions of benzodiazepines
19. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice
20. 1c agonist
21. Behavioural effects of the putative D3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists
22. Signaling via the G protein-activated K+ channels
23. Use of the elevated plus maze in the search for novel anxiolytic agents
24. Animal models of different anxiety states
25. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype?
26. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals
27. Behavioural and pharmacological characterization of the canopy stretched attend posture test as a model of anxiety in mice and rats
28. Behavioral, hormonal and neurochemical characteristics of aggressive alpha-mice
29. Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral "despair"
30. Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines
31. Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action
32. IRK (1-3) and GIRK (1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain
33. Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice
34. Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines
35. Mice, gene targeting and behaviour: More than just genetic background
36. Molecular properties of neuronal G-protein-activated inwardly rectifying K+ channels
37. Interactions of ethanol with benzodiazepine receptor ligands in tests of exploration, locomotion and anxiety
38. The use of a plus-maze to measure anxiety in the mouse
39. The weaver mutant mouse: A model to study the ontogeny of dopamine transmission systems and their role in drug addiction
40. Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice
41. An immunocytochemical study on the distribution of two G-protein-gated inward rectifier potassium channels (GIRK2 and GIRK4) in the adult rat brain
42. Heterotrimeric G proteins: Organizers of transmembrane signals
43. The coupling of neurotransmitter receptors to ion channels in the brain
44. Dopamine D1 binding sites in the striatum of the mutant mouse weaver
45. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation
46. Alteration in expression of G-protein-activated inward rectifier K+ -channel subunits GIRK1 and GIRK2 in the rat brain following electroconvulsive shock
47. G-protein-gated inward rectifier K+ channel proteins (GIRK1) are present in the soma and dendrites as well as in the nerve terminals of specific neurons in the brain
48. Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice
49. Ethopharmacological analysis of the effects of putative "anxiogenic" agents in the mouse elevated plus-maze
50. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety
51. Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT
52. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze
53. Anxiolytic profile of ropinirole in the rat, mouse and common marmoset
54. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box
55. The D3 dopamine receptor in cellular and organismal function
56. Behavioural and pharmacological characterization of the elevated "zero-maze" as an animal model of anxiety
57. Effects of isolation on activity, reactivity, excitability and aggressive behavior in two inbred strains of mice
58. + channel GIRK2
59. Identification of structural elements involved in G protein gating of the GIRK1 potassium channel
60. A G-protein-activated inwardly rectifying K+ channel (GIRK4) from human hippocampus associates with other GIRK channels
61. D3 dopamine receptor-deficient mouse: Evidence for reduced anxiety
62. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors
63. Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release
64. Presynaptic inhibition in the hippocampus
65. Effects of SKF 38393 and quinpirole on aggressive, motor and schedule-controlled behaviors in mice
66. Anxiogenic stimuli in the elevated plus-maze
67. Differences in fear motivated behaviors among inbred mouse strains
68. Learning and anxiety in angiotensin-deficient mice
69. The dopamine D3 receptor: A postsynaptic receptor inhibitory on rat locomotor activity
70. In situ hybridization analysis of GIRK2 expression in the developing central nervous system in normal and weaver mice
71. Presynaptic inhibition of elicited neurotransmitter release